Skip to main content

Find Clinical Trials

Home
Conditions
Hepatitis C Virus

Clinical trial condition

Hepatitis C Virus

Explore clinical trials studying Hepatitis C Virus. Study availability and eligibility vary by location and protocol.

85 public trials 1 recruiting study

Refine in advanced search Browse all conditions

Hepatitis C Virus trial results

Completed

A Study to Evaluate the Safety and Antiviral Effect of ABT-450/Ritonavir and ABT-530 Coadministered With and Without Ribavirin in Adults With Genotype 3 Hepatitis C (HCV) Infection

NCT02068222

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +16 more
Locations: Not specified

View Trial Details

Completed

Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Ribavirin in HCV Genotype 1-Infected Adults With Chronic Kidney Disease

NCT02207088

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +29 more
Locations: Not specified

View Trial Details

Completed

A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin in US Veterans With Genotype 1 Chronic Hepatitis C Virus Infection

NCT02442284

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +18 more
Locations: Not specified

View Trial Details

Completed

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ABT-493 and ABT-530 With and Without Ribavirin in Adults With HCV Who Failed a Prior DAA Containing Therapy

NCT02446717

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +18 more
Locations: Not specified

View Trial Details

Completed

A Randomized, Open-Label Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir Co-administered With Ribavirin (RBV) in Adults With Genotype 4 Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis (AGATE-1)

NCT02265237

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +15 more
Locations: Not specified

View Trial Details

Completed

A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With Ribavirin in Adults With Genotype 1 and Ombitasvir/Paritaprevir/Ritonavir With Ribavirin in Adults With Genotype 4 Chronic Hepatitis C Virus Infection and Decompensated Cirrhosis

NCT02219477

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +18 more
Locations: Not specified

View Trial Details

Completed

Study of Long-term Peg Intron vs. Colchicine in Non-responders.

NCT00179413

Conditions: Advanced Fibrosis, Blood-Borne Infections, Cirrhosis, +14 more
Locations: Birmingham Gastroenterology Associates Birmingham, Alabama, United States

UAMS Medical Center Little Rock, Arkansas, United States

34th Street Community Health Center Bakersfield, California, United States

UC Davis Medical Center Sacramento, California, United States

View all 49 locations

View Trial Details

Completed

Association Between Hepatitis C Virus Infection and Hematologic and Thyroid Cancers

NCT00342641

Conditions: Blood Protein Disorders, Blood-Borne Infections, Cardiovascular Diseases, +29 more
Locations: Houston Veterans AFfairs Medical Center Houston, Texas, United States

View Trial Details

Completed

A Study to Evaluate the Pharmacokinetic Effect of SCH 503034 (Boceprevir) on Methadone or Buprenorphine/Naloxone Plasma Concentrations (P08123)

NCT01396005

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
Locations: Not specified

View Trial Details

Completed

Study to Assess Efficacy, Safety, Tolerability and Pharmacokinetics of Simeprevir, Daclatasvir and Sofosbuvir in Treatment-naive Participants With Chronic Hepatitis C Virus Genotype 1 Infection

NCT02349048

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +13 more
Locations: Bakersfield, California, United States

Jacksonville, Florida, United States

Lutherville, Maryland, United States

Winston-Salem, North Carolina, United States

View Trial Details